KP Tissue Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other Receivables	1.8	1.8	2.45	2.37	1.99
Receivables	1.8	1.8	2.45	2.37	1.99
Total Current Assets	1.8	1.8	2.45	2.37	1.99
Long-Term Investments	69.8	69.52	68.16	79.34	78.73
Total Assets	71.6	71.32	70.61	81.71	80.72
Other Current Liabilities	1.8	1.8	2.25	1.96	4.04
Total Current Liabilities	1.8	1.8	2.25	1.96	4.04
Long-Term Deferred Tax Liabilities	-	-	-	5.72	0.81
Total Liabilities	1.8	1.8	2.25	7.68	4.85
Common Stock	23	22.76	22.56	22.38	21.84
Additional Paid-In Capital	144.82	144.82	144.82	144.82	144.82
Retained Earnings	-114.99	-116.67	-115.03	-108.01	-103.56
Comprehensive Income & Other	16.96	18.61	16.01	14.84	12.77
Shareholders' Equity	69.8	69.52	68.36	74.03	75.87
Total Liabilities & Equity	71.6	71.32	70.61	81.71	80.72
Filing Date Shares Outstanding	10.02	9.99	9.97	9.95	9.93
Total Common Shares Outstanding	10.02	9.99	9.96	9.95	9.9
Working Capital	-	-	0.2	0.41	-2.05
Book Value Per Share	6.97	6.96	6.86	7.44	7.67
Tangible Book Value	69.8	69.52	68.36	74.03	75.87
Tangible Book Value Per Share	6.97	6.96	6.86	7.44	7.67

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.